FindTrial
Sign In

Protective action of an ayurvedic formulation punarnavshtak kwath in various liver probelms like jaundice, hepatitis etc.

Clinical study of Punarnavashtak kwath in hepatic disorders

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2009/091/000719
Enrollment
Unknown
Registered
2009-09-22
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Intervention1: Health intervention: dose 20 ml daily for two month Control Intervention1: Nil: NIL

Sponsors

LM collge of pharmacy, Ahmedabad,
Lead Sponsor
APMC college of pharamceutical education and Research, himatnagar
Collaborator

Eligibility

Inclusion criteria

Inclusion criteria: Sex: both male and female. Age: 18-70. Newly diagnosed cases of hepatic disorder Patients having abnormal liver function tests associated with liver or other disorder

Exclusion criteria

Exclusion criteria: Patients having evidence of extensive disease that requires hospitalization, and pregnant women were excluded from the study

Design outcomes

Primary

MeasureTime frame
The predefined primary end points were clinical and laboratory evidence of normal functioning of liverTimepoint: Measurement of AST, ALT, ALP, BILIRUBIN—

Secondary

MeasureTime frame
To see the efficacy of Punarnavshtak kwath in liver disorderTimepoint: In terms of sense of well being. Nausea, vomiting, appetite, and Blood pressure—

Countries

India

Contacts

Public ContactDr Tapan vaidya

Reg No F/1081/ ahmedabad

vdtapan@hotmail.com07926581036

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026